UNSPSC 51332808: Ciclofenazine or cyclophenazine

This classification denotes a serotonin antagonist and dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OH4ZJ36RB2. European Medicines Agency schedules Ciclofenazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06241MIG. Ciclofenazine generally arises in the molecular formula C23H26F3N3S.

The term CICLOFENAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 10, 1968, list 8.) CICLOFENAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Ciclofenazine or cyclophenazine bears US NLM identifiers UMLS ID C2825451 and NCI Concept Code C81097. SMILES: C1CC1N2CCN(CC2)CCCN3C4=CC=CC=C4SC5=C3C=C(C=C5)C(F)(F)F.

UNSPSC 51332808 Ciclofenazine or cyclophenazine is a Commodity code with limited recent state and local procurement activity. The single recent opportunity on record shows a material mismatch between the code's pharmaceutical scope and actual buying patterns: Seminole County, Florida posted an IFB in June 2026 for naloxone and drug deactivation systems, products unrelated to ciclofenazine. The code does not reflect current state and local contracting patterns for the named pharmaceutical ingredient.

Absent additional opportunities in the recent record, no reliable characterization of issuing-body mix, geographic concentration, or representative purchasing trends can be drawn. The single Seminole County IFB (IFB60459723LAS, due July 26, 2023) is misaligned with the code's stated scope and does not establish a market signal for ciclofenazine or cyclophenazine procurement at state or local level.